Skip to main content
Top

Experimental Hematology & Oncology

Issue 1/2020

Content (37 Articles)

Open Access Research

The SMAC mimetic LCL-161 selectively targets JAK2V617F mutant cells

Brianna M. Craver, Thanh Kim Nguyen, Jenny Nguyen, Hellen Nguyen, Christy Huynh, Sarah J. Morse, Angela G. Fleischman

Open Access Myelodysplastic Syndrome Research

Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia

Jifeng Yu, Yingmei Li, Tao Li, Yafei Li, Haizhou Xing, Hui Sun, Ling Sun, Dingming Wan, Yanfang Liu, Xinsheng Xie, Zhongxing Jiang

Open Access Acute Myeloid Leukemia Review

Clinical implications of recurrent gene mutations in acute myeloid leukemia

Jifeng Yu, Yingmei Li, Danfeng Zhang, Dingming Wan, Zhongxing Jiang

Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis

Shih-Hsuan Chao, Yuh-Lih Chang, Jiin-Cherng Yen, Hsien-Tzung Liao, Tsai-Hung Wu, Chia-Li Yu, Chang-Youh Tsai, Yueh-Ching Chou

Open Access NSCLC Research

Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial

Vivek Subbiah, Ecaterina Ileana Dumbrava, Yunfang Jiang, Kyaw Z. Thein, Aung Naing, David S. Hong, Siqing Fu, Sarina A. Piha-Paul, Apostolia M. Tsimberidou, Filip Janku, Funda Meric-Bernstam, Razelle Kurzrock, Gerald Falchook

Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma

Xi Yun Zhang, Deepa Rajagopalan, Tae-Hoon Chung, Lissa Hooi, Tan Boon Toh, Johann Shane Tian, Masturah Bte Mohd Abdul Rashid, Noor Rashidha Bte Meera Sahib, Mengjie Gu, Jhin Jieh Lim, Wilson Wang, Wee Joo Chng, Sudhakar Jha, Edward Kai-Hua Chow

Lymphoma Letter to the Editor

The effects of B cell depletion on immune related adverse events associated with immune checkpoint inhibition

Rasmus Strøm Risbjerg, Mie Vennize Hansen, Anne Sofie Sørensen, Tue Wenzel Kragstrup

Open Access Hepatocellular Carcinoma Research

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma

Furong Liu, Lu Qin, Zhibin Liao, Jia Song, Chaoyi Yuan, Yachong Liu, Yu Wang, Heze Xu, Qiaofeng Zhang, Youliang Pei, Hongwei Zhang, Yonglong Pan, Xiaoping Chen, Zhanguo Zhang, Wanguang Zhang, Bixiang Zhang

Open Access CAR T-Cell Therapy Research

Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes

Liqing Kang, Xiaowen Tang, Jian Zhang, Minghao Li, Nan Xu, Wei Qi, Jingwen Tan, Xiaoyan Lou, Zhou Yu, Juanjuan Sun, Zhenkun Wang, Haiping Dai, Jia Chen, Guoqing Lin, Depei Wu, Lei Yu

Prostate Cancer Short report

Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation

Jingjing Wu, Shundong Cang, Christina Liu, Whitman Ochiai, Jen Wei Chiao

Open Access Metastasis Research

RDGN-based predictive model for the prognosis of breast cancer

Bing Dong, Ming Yi, Suxia Luo, Anping Li, Kongming Wu

Open Access Chronic Lymphocytic Leukemia Research

Leukemia incidence trends at the global, regional, and national level between 1990 and 2017

Ying Dong, Oumin Shi, Quanxiang Zeng, Xiaoqin Lu, Wei Wang, Yong Li, Qi Wang

Macrophage, the potential key mediator in CAR-T related CRS

Zhaonian Hao, Ruyuan Li, Li Meng, Zhiqiang Han, Zhenya Hong

Open Access NSCLC Research

The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in China

Yanhui Chen, Yating Wang, Hongli Luo, Xue Meng, Wei Zhu, Di Wang, Hui Zeng, Henghui Zhang

Open Access Cytostatic Therapy Letter to the Editor

Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models

Pei Pei Che, Alessandro Gregori, Omidreza Firuzi, Max Dahele, Peter Sminia, Godefridus J. Peters, Elisa Giovannetti

Open Access Human Papillomavirus Letter to the Editor

Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study

Il Seok Daniel Jeong, Huan Mo, Anthony Nguyen, Esther G. Chong, Hsin Hsiang Clarence Tsai, Justin Moyers, Matthew Kim, Curtis Lacy, Vivek Shah, Eric Lau, Yi Xu, Huynh Cao

Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study

Immacolata Tartaglione, Raffaella Origa, Antonis Kattamis, Michael Pfeilstöcker, Sibel Gunes, Susanne Crowe, Niamh Fagan, Beatrice Vincenzi, Giovan Battista Ruffo

Open Access Stem Cell Transplantion Research

Risk factors and outcome of COVID-19 in patients with hematological malignancies

José Luis Piñana, Rodrigo Martino, Irene García-García, Rocío Parody, María Dolores Morales, Gonzalo Benzo, Irene Gómez-Catalan, Rosa Coll, Ignacio De La Fuente, Alejandro Luna, Beatriz Merchán, Anabelle Chinea, Dunia de Miguel, Ana Serrano, Carmen Pérez, Carola Diaz, José Luis Lopez, Adolfo Jesús Saez, Rebeca Bailen, Teresa Zudaire, Diana Martínez, Manuel Jurado, María Calbacho, Lourdes Vázquez, Irene Garcia-Cadenas, Laura Fox, Ana I. Pimentel, Guiomar Bautista, Agustin Nieto, Pascual Fernandez, Juan Carlos Vallejo, Carlos Solano, Marta Valero, Ildefonso Espigado, Raquel Saldaña, Luisa Sisinni, Josep Maria Ribera, Maria Jose Jimenez, Maria Trabazo, Marta Gonzalez-Vicent, Noemí Fernández, Carme Talarn, Maria Carmen Montoya, Angel Cedillo, Anna Sureda

Open Access Graft-Versus-Host Disease Research

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells

Yong-Rim Kwon, Hye Joung Kim, Min-Jung Sohn, Ji-Young Lim, Kyung-Shin Park, Seok Lee, Nack-Gyun Chung, Dae-Chul Jeong, Chang-Ki Min, Yoo-Jin Kim

Open Access Pancreatic Cancer Review

Regulation of metabolic reprogramming by tumor suppressor genes in pancreatic cancer

Mengqi Liu, Wensheng Liu, Yi Qin, Xiaowu Xu, Xianjun Yu, Qifeng Zhuo, Shunrong Ji

Open Access Adenovirus Letter to the Editor

Frontiers in the COVID-19 vaccines development

Ehtisham Ul Haq, Jifeng Yu, Jiancheng Guo

Open Access Mantle Cell Lymphoma Research

miR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR

Luhui Lin, Yiqun Huang, Wei Zhuang, Ping Lin, Xudong Ma

Open Access Hepatocellular Carcinoma Review

Complex roles of cAMP–PKA–CREB signaling in cancer

Hongying Zhang, Qingbin Kong, Jiao Wang, Yangfu Jiang, Hui Hua

Open Access Probiotics Review

Applications of gut microbiota in patients with hematopoietic stem-cell transplantation

Jifeng Yu, Hao Sun, Weijie Cao, Lijie Han, Yongping Song, Dingming Wan, Zhongxing Jiang

Open Access Biomarkers Review

CD44 as a tumor biomarker and therapeutic target

Hanxiao Xu, Mengke Niu, Xun Yuan, Kongming Wu, Aiguo Liu

Open Access Chronic Lymphocytic Leukemia Letter to the Editor

Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country

Ana Muntañola, Guillermo Villacampa, José Ángel Hernández-Rivas, Rosalía Alonso, Fátima Mirás, Santiago Osorio, Mónica Baile, Patricia Baltasar, Javier López Jiménez, Ines Hernandez-Rodriguez, Susana Valenciano, Ana Alfayate, Eva Gimeno, Abelardo Bárez, Ana C. Oliveira, Rosalía Riaza, Pilar Romero, Julio Delgado, Lucrecia Yáñez, Amaya Zabalza, Ana Torres, Mª Isabel Gómez-Roncero, Marta Crespo, Raúl Córdoba, Juan José Mateos-Mazón, Sonia Pérez, Rafael Andreu, Jorge Labrador, Mª Elena Ruiz, César Andrés Velasquez, Mª José Terol, Raquel Santiago, Mª Jesús Vidal, Fiz Campoy García, Lucía Villalón, Begoña S. Muiña, Joan Alfons Soler, Cristina Seri, Mª José Sánchez, Amalia Cuesta, Rafael Ramos, Adrián Sánchez-Montalvá, Isabel Ruiz-Camps, Marcos González, Pau Abrisqueta, Francesc Bosch

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine